Non-coding RNA Research (Mar 2020)

The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker

  • Tatsuya Ishikawa,
  • Arisa Haino,
  • Mineaki Seki,
  • Taro Kurihara,
  • Takayuki Hirose,
  • Yosuke Imai,
  • Takuro Ishiguro,
  • Takaaki Chou,
  • Muneatsu Toshima,
  • Hiroshi Terada,
  • Masayuki Nashimoto

Journal volume & issue
Vol. 5, no. 1
pp. 37 – 40

Abstract

Read online

The 31- and 32-nt 5′-fragment of Y4-RNA (Y4RNAfr) exists abundantly in human peripheral blood plasma. Although physiological roles of the plasma Y4RNAfr are not well established, its potential utility as a diagnostic/prognostic marker for acute coronary syndrome was suggested. In this paper, to establish a normal range of the Y4RNAfr level in plasma, we measured plasma Y4RNAfr levels of 40 healthy persons using the method we have developed, and compared them with other blood test data. From the obtained data, we tentatively regarded <0.1 fmol/ng as normal for the Y4RNAfr level in peripheral blood plasma. And the white blood cell count (WBC) and the C-reactive protein (CRP) level showed moderate positive correlations with the Y4RNAfr level, suggesting that Y4RNAfr could be a potential novel inflammatory marker. We also measured the Y4RNAfr level in peripheral blood plasma from four multiple myeloma patients. The plasma Y4RNAfr level was abnormal in all four myeloma patients, and the levels for two patients were far beyond the normal level. The WBC for each patient was normal and the CRP levels for two patients were normal. These observations together suggest that a high level of Y4RNAfr in peripheral blood plasma and a normal WBC could be indicative of multiple myeloma. Keywords: Y4-RNA fragment, qRT-PCR, Plasma, Inflammatory marker, Multiple myeloma, White blood cell, C-reactive protein